Form 4 for SONM DNA X, Inc.
Accepted 2024-06-24 00:00:00 ET · period of report 2024-06-20 · accession 0001493152-24-024962 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-24 | 2024-06-21 | SONM | Steenstra Jack | Dir | S - Sale | $0.69 | -35.9K | 274.1K | -12% | -$24.8K | |
| 2024-06-24 | 2024-06-20 | SONM | Steenstra Jack | Dir | A - Grant | $0.00 | +78.9K | 310.0K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-21 | S | D | 35,882 | $0.69 | 274,145 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.69 to $0.74, inclusive. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a securityholder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. (F5) Consists of (i) 132,649 shares of common stock and (ii) 141,496 unvested restricted stock units. |
| 2 | Common | Common Stock | 2024-06-20 | A | A | 78,947 | $0.00 | 310,027 | D | — | — | (F1) Represents the grant of restricted stock units that vest in one installment on the earlier of the first anniversary of the grant date, immediately prior to the next annual meeting of stockholders, a change in control of the Issuer, or the Reporting Person's death or disability, subject to the Reporting Person's continued service to the Issuer. Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock. (F2) Consists of (i) 168,531 shares of common stock and (ii) 141,496 unvested restricted stock units. |